Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – FDA approves expanded use of Bristol-Myers’ skin cancer drug

[Reuters] – Bristol-Myers Squibb Co said the U.S. Food and Drug Administration had approved the expanded use of its cancer drug, Opdivo, to treat an additional form of advanced skin cancer. The company . . . → Read More: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – FDA approves expanded use of Bristol-Myers’ skin cancer drug Similar Articles: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb’s Opdivo (nivolumab) Recipient of Prix Galien USA 2015 Award for Best Biotechnology Product Company Update (NYSE:BMY): FDA expands lung cancer approval for Bristol-Myers’ drug Stock Update (NYSE:BMY): FDA approves Bristol Myers’ combination treatment for skin cancer